The IRA has Medicare taking the role of a European HTA, this has enormous implications for U.S. Biopharma innovation. Rhythm I Am Biotech Duane Schulthess Better Science Better Health omny.fm/shows/vital-he…

PODCAST: Biocom California Grapples with Regulatory Assaults on all Fronts -> bit.ly/44vNI7N Duane Schulthess Better Science Better Health Biocom California Joe Panetta

PODCAST: IRA is causing cuts to California biotech R&D -> bit.ly/44vNI7N Joe Panetta Biocom California Duane Schulthess Better Science Better Health

PODCAST: Best-of Vital Health Podcast - looking back on the COVID-19 outbreak -> bit.ly/3DRKm3i Duane Schulthess Better Science Better Health Martin Kulldorff Wilfred Reilly

Amy Millier and the PhRMA Foundation Push the R&D Envelope PODCAST: bit.ly/48q1ACA PhRMA Foundation Duane Schulthess @vitaltransform Better Science Better Health

“IRA Drug Selection Politics Has Investors Fleeing” PODCAST: bit.ly/48tqtgW Steven Potts AZBio Duane Schulthess Better Science Better Health VitalTransformation

PODCAST: bit.ly/3FFmrVl Bettina Ryll #melanoma #MPNE Duane Schulthess VitalTransformation Better Science Better Health

🗓️MSD Early Bird 👇 Join us on 21 Nov 8.30 am CET for the upcoming Early Bird Debate and engage with two experts as they debate why 1+1 does not equal 3! us02web.zoom.us/webinar/regist… MSD Europe #CancerCareDebate VitalTransformation moderated by Duane Schulthess

Using march-in to control prices will be ineffective – Only 5 of the 361 novel therapies in our cohort include government interest statements covering all mechanism of action and composition of matter patents Full research 👉 bit.ly/3GnnWYN Bayh-Dole Coalition I Am Biotech

NIH’s fair pricing clauses failed when previously tried. They have, “driven industry away from potentially beneficial scientific collaborations . . .without providing an offsetting benefit to the public,” said NIH’s Dr Varmus. 👉 bit.ly/3GnnWYN Bayh-Dole Coalition I Am Biotech

For 15 FDA approved products with patents containing a government interest statement, the total industry contribution was $44.3 billion, while the government contribution was $276 million, 1/160th of the total funding required for their development. 👉 bit.ly/3GnnWYN

The AAM opposes the suggested use of price as a reason to exercise march-in rights, referencing recent research from VitalTransformation bit.ly/49XPiS6 Duane Schulthess -> read their comments here bit.ly/4c6Cv1x

Commentary Boston Business Journal: bit.ly/3Pdpzgk The IRA’s impact on medical innovation by would lead to nearly 230 fewer FDA approvals of new medicines or new uses over 10 years -> the research here by VitalTransformation bit.ly/4a3yzgb The New England Venture Capital Association Ari F. Glantz

GetReal Conference 14-15 May 2024 A Growing Convergence: RWE for Regulatory and HTA Decision-Making This year’s event continues the journey to shape the future of RWE in Regulatory and HTA decision-making. Register now, early bird ends tomorrow! -> getreal-conference.org

PODCAST: NIH money is dwarfed by the funding by industry --> bit.ly/48RPYY9 Duane Schulthess Bayh-Dole Coalition I Am Biotech VitalTransformation Better Science Better Health

Kate Hudson & Joseph P. Allen – The Fact Free Attacks on IP Bayh-Dole Coalition Kate Hudson I Am Biotech Win Boerckel omny.fm/shows/vital-he…

The GetReal Institute Annual Conference 2024 A Growing Convergence: RWE for Regulatory & HTA Decision-Making, 14-15 May What will be discussed and who will participate? Discover the full programme bit.ly/3TqsBPU Registration here -> bit.ly/3VnjNNe

PODCAST: The Fact Free Attacks on IP -->bit.ly/4cwv0Ba Duane Schulthess Bayh-Dole Coalition VitalTransformation Better Science Better Health AAU

GetReal Institute 2024 Annual Conference: Editor’s highlights evidencebaseonline.com/getreal-instit…

John LaMattina – Drug Price Controls and IP Attacks Get Real omny.fm/shows/vital-he… John LaMattina PureTech Forbes Duane Schulthess VitalTransformation Better Science Better Health